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ABSTRACT
Objective: The current investigation focuses on the study of efficacy of whole plant of Polycarpaea corymbosa Lamk in Ehrlich ascites carcinoma (EAC) 
inoculated Swiss albino mice.
Methods: The whole plant of P. corymbosa Lamk (WPC) was extracted with solvents of increasing polarity and their percentage yields were calculated. 
The major phytoconstituents present in the plant extracts were determined by standard chemical tests. Tumor was induced in mice by intraperitoneal 
injection of EAC cells (1×106 cells/mouse). The in vivo antitumor effect of extracts was assessed by monitoring the mean survival time, tumor volume, 
effect on hematological parameters, determination of lysosome specific cancer markers (cathepsin-D), β-D glucuronidase and acid phosphatase, liver 
marker enzymes (5’-nuclotidase and lactate dehydrogenase), membrane bound ATPase (Na+/K+ ATPase and Mg2+ ATPase), DNA, and RNA content.
Results: The percentage yield obtained were 9.87%w/w, 7.88%w/w, and 16.56% w/w for petroleum ether, ethyl acetate, and ethanol extract, 
respectively. The phytochemical screenings of those extracts were performed. The order of activity of extracts was ethanol extract > ethyl acetate > 
petroleum ether. Among the extracts, Ethanol extract of P. corymbosa Lamk. showed a significant increase in life span and decrease in viable cancer 
cell number and tumor volume. The protective effect of the extract on the hemopoietic system at the dose 200mg∕kg was noted. The alterations in the 
hematological profile, lysosome-specific cancer markers, liver-specific cancer markers, and membrane-bound ATPases DNA and RNA were restored.
Conclusion: The ethanolic extract of P. corymbosa Lamk. possesses in vivo anticancer activity when compared to the tumor control group.
Keywords: Breast cancer, Polycarpaea corymbosa Lamk; Ehrlich ascites carcinoma, Phytochemistry, Flavonoids, Cancer markers, Membrane transport 
protein, Nuclei acids, Anticancer.
INTRODUCTION
Cancer is the second most cause of the death worldwide which is 
characterized by abnormal growth of cells due to the insensitivity of 
genes. It affects people at all ages [1] where damage to the genetic 
material of the malignant cells in progeny was observed in common. 
The imbalance in pro-oxidant and antioxidant is an important 
cause of cancer. The oxidative stress build up in turn generates 
reactive oxygen species inside the cell which further progresses 
to cellular transformation, genomic instability, hyperproliferation, 
immortalization, angiogenesis, and metastasis [2]. Understanding the 
key enzymes involved in the disease progression is important to identify 
the new drug targets. The screening of new molecules or natural agents 
with potential antitumor activity was vital to spot the right drug for 
treating the disease with ease. Hence, the requirement of substitutes 
for the conservative chemotherapeutic drugs which is economical, easy 
accessible, and therapeutically active at nontoxic doses and combats 
chemoresistance to control the disease progress is required [1].
The plants which belong to the Caryophyllaceae family have potential 
source of secondary metabolites and have many medicinal properties [3]. 
The whole plant Polycarpaea corymbosa Lamk belongs to the family 
Caryophyllaceae (Synonyms- Achyranthus corymbosa). P. corymbosa Lamk 
was an annual or perennial herb consisted leaves which were opposite or 
appear in whorls, linear up to 3.5 cm long with a brittle at the tip. The 
flowering season of this plant was from August to September. Flowers 
were borne in compact heads at the end of stems. Sepals were silvery 
white, turning rich brown with age. Petals were small, pink to orange in 
color. Fruit was a minute ellipsoid capsule. It was distributed in India, 
Burma, Ceylon, Western Peninsula and ascending the western Himalayas 
to 7000 feet [4]. It was used both internally and externally as remedy 
for venomous bites from reptiles and animals [5]. In traditional Chinese 
medicine, it was used to treat cough and in Indian traditional medicine; 
it was used in the treatment of jaundice and inflammatory swellings [6]. 
This plant has proven antioxidant [7-10], anti-inflammatory [11,12], 
antiulcer [13-15], antidiarrheal [16], antimicrobial [17], analgesic [18], 
hepatoprotective [8,19, 20], and androgenic [21] properties. The 
cytotoxic potential against colorectal adenocarcinoma, breast cancer, 
leukemia, and prostate carcinoma of human cell lines were evaluated, in 
which potential activity against breast cancer cell line [22] was observed. 
Hence, the current study was investigated to determine its efficacy in 
Ehlrich ascites carcinoma (EAC)-induced mice, an in vivo model.
MATERIALS AND METHODS
Collection and identification of plant
The whole plant of P. corymbosa Lamk (WPC) was collected in the month 
of August and September from Palayamkottai, Tirunelveli District, 
Tamil Nadu, India. The taxonomic identification of the material was 
authenticated by Dr. G.V.S. Murthy, Ph.D., Scientist F and Head, Botanical 
Survey of India, Southern Regional Centre, Coimbatore, India. The plant 
material was dried under shade, segregated, pulverized by a mechanical 
grinder, and passed through a 40 mesh sieve. The powdered plant 
material was stored in airtight containers and used for further research.
Preparation of extracts and preliminary phytochemical screening
The air-dried powdered material of about 2 kg from the whole plant 
was successively extracted by hot continuous percolation method in 
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/
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Soxhlet apparatus by increasing the polarity of the solvents such as 
petroleum ether, ethyl acetate, and ethanol. Solvents used for this 
entire work were of analytical grade (Merck, Mumbai). The extracts 
were collected and filtered through Whatmann filter paper No. 40, 
and the solvents were recovered from the extracts under reduced 
pressure using rotary evaporator. The concentrated filtrate was then 
evaporated to dryness in vacuum at 35–40°C. Then, the extracts were 
stored in screw capped vials at 4°C until further use. The percentage 
yield was calculated with reference to the crude material was 
calculated, and the preliminary phytochemical screening for alkaloids, 
carbohydrates, proteins and amino acids, glycosides, saponins, 
flavonoids, tannins and phenolic compounds, phytosterols, fixed oils, 
and fats was carried out [23,24].
Animals
Swiss Albino mice (25–30 g) were maintained under standard 
laboratory conditions temperature (27±2°C) with relative humidity of 
55±5%, in an experimental room under a 12 h light/12 h dark cycle as 
per CPCSEA. Before the experiment, mice were kept under quarantine 
for a week for acclimatization to the laboratory conditions. They 
were fed with commercial pellet diet and normal drinking water was 
provided ad libitum. The approval of the Institutional Animal Ethical 
Committee was obtained whose reference number is 1/243/CPCSEA 
dated 22 November 2013.
Experimental protocol
Acute toxicity study
As per guideline of Organization of Economic Co-operation and 
Development 423, the acute toxicity studies of petroleum ether, ethyl 
acetate, and ethanol extract of WPC were carried out [25].
Tumor cells
EAC cells were obtained from the Amala cancer Research Centre, Kerala 
(Thrissur), India. The EAC cells were maintained in vivo in Swiss albino 
mice, by intraperitoneal (i.p) injection of 1×106 cells/mouse after every 
10 days [12].
Grouping of animals
Male Swiss albino mice were divided into 6 groups (n=6) and Group I 
served as normal control; Group II served as disease control (Inoculated 
with 1×106 EAC cells/mouse (i.p); Group III treated with pet ether extract 
(200 mg/kg b.w p.o) during induction; Group IV inoculated with 1×106 
EAC cells/mouse and treated with ethyl acetate extract (200 mg/kg b.w 
p.o) and Group V inoculated with 1×106 EAC cells/mouse and treated 
with ethanol extract (200 mg/kg b.w p.o.); Group VI Inoculated with 
1×106 EAC cells/mouse and treated with standard drug 5-fluorouracil 
(20 mg/kg b.w) for 14 days.
Laboratory investigations
Evaluation of body weight:
Body weight of the animals was recorded from the day 1 to day 15 of 
the study. Average body weight at 15th day was determined. The mean 
survival time and percentage increase of life span were calculated using 
the following formula [26].
+
=
(Day of the first death  
Day of the last death)Mean Survival Time (MST)in days  
2
Percentage increase of life span (ILS) = {(MST Test/MST control)−1}×100.
Hematological profile evaluation
After the last dose and 18-hr fasting, blood was collected from six mice 
under mild anesthesia for hematological evaluation in each group 
which includes red blood cells (RBC), hemoglobin (Hb), total white 
blood cells (WBC), and differential count (neutrophils, lymphocytes, 
and monocytes) [27].
Tumor volume
After the treatment period, animals were dissected, and the ascitic fluid 
was collected from the peritoneal cavity and its volume, packed cell 
volume were determined [12], and viability was assessed using trypan 
blue exclusion assay.
Bio markers estimation
One gram of liver tissue was taken and homogenized with 10 ml of 
0.1 M cold tris buffer, pH 7.4 and examined for lysosome specific 
cancer markers (Cathepsin-D) [28], β-D glucuronidase [29], and acid 
phosphatase [30], liver marker enzymes [31] (5’-nuclotidase) and 
lactate dehydrogenase [32], and membrane bound ATPase (Na+/K+ 
ATPase [33] and Mg2+ ATPase [34], DNA [35], and RNA [36,37] content 
were estimated.
Statistical analysis
The results were expressed as mean±SEM or mean±SD.
RESULTS
The percentage yields of petroleum ether, ethyl acetate, and ethanol 
extract of WPC were 9.87% w/w, 7.88% w/w, and 16.56% w/w, 
respectively. The phytochemical screening of petroleum ether extract 
(PEEPC) revealed the presence of phytosterols, fixed oils, and fats. Ethyl 
acetate extract (EAEPC) possess alkaloids, carbohydrates, glycosides, 
fixed oils and fat, saponin, phenolic compounds and tannins, protein, 
and amino acids. The ethanol extract (EEPC) contains alkaloids, 
flavonoids, carbohydrates, glycoside, saponins, phenolic compounds, 
tannins, protein, and amino acids.
Acute toxicity
It was observed that treatment of animals with PEEPC, EAEPC, and 
EEPC did not show any changes in the autonomic or behavioral 
responses. Zero percent mortality was obtained for all the extracts of 
the WPC and hence the extracts were found to be non-toxic up to the 
dose of 2000 mg/kg.
Anticancer study
From Table 1, it was observed that the animals treated with EAC have 
increase in body weight, decrease in mean survival time, percentage 
increase in life span, and increase in tumor volume, packed cell volume, 
and viable cell count than the extract treated groups. On comparing 
within the extracts, group V and VI showed potential activity. Similar 
results were not found in other treatment groups. In Group II, animals 
were died after 18 days of inoculation whereas the life span of group V 
and VI was 6 weeks.
Hematological parameters
The haematological parameters namely RBC, Hb, Total WBC count and 
differential count were observed for various extracts of the WPC as 
furnished in Table 2. In group II, RBC, Hb, Lymphocytes and monocytes 
were found to be decremented whereas total WBC count and neutrophils 
were observed to be incremented. Group V and Group VI has restored 
RBC, Hb, total WBC count and differential count.
Estimation of lysosomal marker enzymes, liver markers, 
Na+/K+- ATPase and Mg+-ATPase, DNA, and RNA
i. The Lysosomal Marker enzymes in liver of experimental groups were 
depicted in Table 3. In Group II, the activity of Cathepsin-D was elevated 
twice (41.19±1.75), than the Group I (21.73±0.19). β-D glucuronidase 
activity was increased (38.78±1.25) by 56%in Group II when compared 
to Group I. The increase in the activity of acid phosphatase was 3-fold 
(9.14±0.24) when compared to Group I. In Groups III - VI, the lysosomal 
marker enzyme levels were decreased compared to Group II.
ii. Table 4 depicts the activity of liver marker enzymes 5’-nucleotidase 
and LDH in experimental groups. The level of 5’-nucleotidase in Group II 
was elevated thrice (6.46±0.25) when compared to Group I (2.58±0.10). 
Nucleotidase activity is increased when tumor occluding the bile ducts. 
116
Asian J Pharm Clin Res, Vol 14, Issue 10, 2021, 114-118
 Abirami and Muthusamy
In Group III-VI, the marker enzyme levels were decreased compared 
to the Group II. LDH activity in the liver of Group II (0.41±0.12) 
was markedly declined in comparison to Group I (1.59±0.10). In 
Group III-VI, the increase in LDH level of liver was observed compared 
to the Group II.
iii. Table 5 illustrated that the effect of different extracts of WPC on the 
activities of ATPases, nucleic acids in liver of normal and experimental 
group of animals. When compared to Group I, Na+/K+-ATPase activity 
was decreased significantly by 2-fold; the decrement in the activity 
of Mg2+-ATPase was found to be 56% in Group II. The increment in 
enzymes was observed in other treatment groups. The level of DNA 
in Group II gets elevated by 4-fold; when compared to Group I. The 
increment in the levels of RNA in Group II was found to be 55% when 
compared to Group I. In Group III-VI, the marker enzyme levels were 
decreased compared to Group II.
DISCUSSION
The phytoconstituents were responsible for the therapeutic properties of 
the plants [24]. From the phytochemical screening, it was found that the 
numbers of phytoconstituents were more in ethanol extract followed by 
ethyl acetate extract and petroleum ether extract. All these extracts were 
found to be nontoxic up to the dose 2000 mg/kg in acute toxicity study. 
Based on the in vitro cytotoxic evaluation on various cell lines, the whole 
plant of P. corymbosa Lamk. exhibited potential activity against breast 
cancer cell line [22]. EAC is an experimental breast cancer derived from 
spontaneous mouse adenocarcinoma. EAC causes rapid buildup and 
accumulation of ascitic fluid [38] in the peritoneal cavity. In EAC bearing 
mice, the body weight, ascitic volume [39], and viable cell count was 
increased. Supplementation of WPC extract reverses the altered levels 
of body weight, MST, percentage of life span, tumor volume, PCV and 
incremented, the non-viable cell count indicating its cytotoxicity toward 
Table 1: Body weight, Mean survival time, Percentage increase in life span, Tumour volume, PCV and Tumour cell count of various 
experimental animals treated WPC extracts
Groups Bodyweight(g) Mean 
survival 
time (days)




Tumour cell count 
(1×107 cells/ml)
Viable Non- viable
Group II 36.10±0.58 17.08±0.68 - 2.81±0.11 1.3±0.10 11.82±0.92 0.34±0.02
Group III 33.20±0.27 18.61±0.98 28.06 2.67±0.08 1.1±0.81 10.32±0.87 0.38±0.11
Group IV 29.91±0.07 20.19±0.71 37.48 2.10±0.09 0.98±0.17 9.11±0.25 0.51±0.22
Group V 26.91±0.91 29.18±0.91 59.67 1.90±1.16 0.53±0.07 7.62±0.25 0.68±0.03
Group VI 26.45±0.16 32.17±2.01 86.93 - - - -
Values were expressed as Mean±SD for 6 mice in each group
Table 2: Effect of WPC on haematological parameters 
Groups RBC (106/mm3) Hb (g/dl) WBC (103/cu.mm) Differential count (%)
Neutrophils Lymphocytes Monocytes
Group I 4.54±0.28 11.92±0.31 9.75±0.53 16.40±0.63 81.48±3.12 1.49±0.11
Group II 2.11±0.09 6.92±0.11 15.73±0.36 61.17±2.17 35.24±1.24 0.84±0.03
Group III 3.45±0.11 8.44±0.96 13.31±0.35 52.27±2.31 40.92±2.44 0.95±0.06
Group IV 4.08±0.22 10.08±0.62 11.78±0.42 38.27±2.31 53.42±2.79 1.07±0.06
Group V 4.21±0.72 11.22±0.52 10.93±0.39 17.04±0.62 71.42±2.79 1.25±0.06
Group VI 4.48±0.21 11.59±0.17 9.67±0.35 16.60±1.97 75.11±1.98 1.32±0.04
Values are expressed as Mean±S.D. (n=6)
Table 3: Effect of various extracts of WPC on the activities 
of lysosomal markers enzymes in liver of normal and 













(μmoles of π 
liberated/min/
mg protein)
Group I 21.73±0.19 24.93±0.79 3.79±0.11
Group II 41.19±1.75 38.78±1.25 9.14±0.24
Group III 33.27±1.53 33.14±1.17 8.75±0.80
Group IV 29.30±1.10 30.10±0.70 6.27±0.20
Group V 26.12±1.27 25.90±0.59 4.18±0.14
Group VI 22.52±0.77 24.32±0.82 3.38±0.09
Values expressed as mean±S.D for 6 mice in each group
Table 4: Effect of various extracts of WPC on the activities of 






Group I 2.58±0.10 1.59±0.10
Group II 6.46±0.25 0.41±0.12
Group III 5.88±0.17 0.43±0.53
Group IV 4.37±0.16 0.48±0.09
Group V 3.17±0.17 1.18±0.08
Group VI 3.38±0.16 1.25±0.08
Values are expressed as mean±SEM for 6 mice in each group
Table 5: Effect of various extracts of WPC on the activities 
of Na+/K+- ATPase and Mg+-ATPase in liver of normal and 













Group I 1.88±0.11 2.71±0.12 3.67±0.15 10.85±0.52
Group II 0.93±0.15 1.22±0.07 7.49±0.34 16.84±0.67
Group III 1.06±0.08 1.52±0.09 5.98±0.81 14.67±0.27
Group IV 1.37±0.08 2.27±0.08 4.45±0.17 13.14±0.50
Group V 1.61±0.08 2.58±0.08 3.98±0.61 11.52±0.59
Group VI 1.83±0.08 2.67±0.09 3.72±0.14 11.08±0.43
Values are expressed as mean±SD (n=6). (1 unit = µ moles of π liberated/min)
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cancer cells. The order of efficacy of extracts wasEEPC > EAEPC > PEEPC. 
The EEPC has potential antitumor activity similar to that of reference 
drug, 5- Fluorouracil. On hematological investigation, the decrease in 
RBC and hemoglobin was found which may be due to the deficiency of 
iron or due to the hemolytic or myelopathic conditions in EAC mice [40]. 
The significant increase in WBC count and neutrophils in tumor bearing 
mice was due to its primary defense mechanism [41]. Decreased 
lifespan was due to the low Hb levels in cancerous condition [42]. 
The above conditions were reversed in drug treated groups which 
evidenced the protective action of WPC extracts on the hematopoietic 
system. Because of free radical generation in cancer cells, the leakage 
of lysosomal enzymes [43] occurs due to loss of membrane integrity. 
Lysosomal specific marker enzymes include Cathepsin–D [44-46], Acid 
phosphatase and β-D-glucuronidase [47-50]. Liver enzyme markers 
such as 5’nucleotidase [51], Lactate dehydrogenase [52-54], potential 
tumor markers used to assess the progression of the proliferating 
malignant cells. Among the various extracts of WPC, EEPC produces 
potential action which may be due to the presence of flavonoids which 
scavenges the free radicals and protects membrane integrity [36,38,55]. 
Treatment with EEPC elevates antioxidant enzymes such as serum 
total protein, superoxide dismutase, catalase, reduced glutathione, and 
glutathione peroxidase activity in CCl4 induce hepatotoxicity [8] and 
alloxan-induced diabetic rats [7]. Oxidative stress accumulation causes 
significant decrease in the ion transport proteins [56] such as sodium 
potassium ATPase and magnesium ATPase in liver of cancer bearing 
mice [57,58]. Chemo resistance occurs by this mechanism due to efflux 
of drugs from transport proteins [59]. In the EEPC treated EAC-control, 
membrane bound ATPase levels were increased. Flavonoids influence 
the permeability of bio membranes by interacting with ATPase pumps 
in the animal cell thereby regaining their normal efficiency [59] and 
resumed the normal function [60]. Elevated levels of hepatic nucleic 
acids DNA and RNA were observed in disease control [61-64] but in 
treatment groups, reduction in their levels were observed. Attainment of 
nucleic acids levels to near normal was observed in EEPC treated groups. 
This proves that the drug has the potential to inhibit the proliferation 
of cancer cells, can stabilize, and restore the system to its normal 
physiological function.
As per literature, the chief constituents present in WPC were lupeol [65], 
stigmasterol [66], beta sitosterol [66], gamma sitosterol [66], 
camelligenin A [67], apoanagallosaponin IV [67], 5 hydroxy methyl 
furfural [68], and 9, 2, hexadecanoic acid [68]. These compounds were 
known for its anticancer property in various malignant neoplasms. In 
breast cancer, lupeol acts by downregulating the Bcl-2 and bcl-XL protein 
expression which induces the apoptosis process in breast cancer cell 
line MCF-7 [69], it also reduces cell migration in non-small cell lung 
cancer[70,71]. Phytosterols such as Stigmasterol and beta sitosterol 
showed cytotoxic potential against breast cancer cell line [72]; the 
stigmasterol reduces the tumor development by activation of protein 
phosphatase 2A causing apoptosis in EAC induced mice via stimulation 
of antioxidant enzymes [73].
CONCLUSION
From the above findings, it was concluded that P. corymbosa Lamk. 
possess antitumor activity. The mechanism by which it elucidates its 
anticancer potential has to be determined.
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